TLDR
- Elon Musk revealed the Terafab project will begin operations in 7 days at Tesla’s Austin Gigafactory campus as a chip production facility
- The manufacturing plant aims to prevent a chip supply constraint that Musk anticipates could hinder Tesla’s expansion within 3–4 years
- Tesla’s ambitious Optimus robot production goals may demand 200 million+ chips annually — a 50-fold increase over current requirements
- Morgan Stanley’s Andrew Percoco projects the fabrication plant could require $35B–$40B investment with chip production starting around 2028
- Musk highlighted geopolitical considerations as a primary motivation for establishing domestic chip manufacturing capabilities
Tesla shares advanced 0.6% during early Wednesday trading, reaching $401.75, following CEO Elon Musk’s confirmation that the company’s “Terafab” chip manufacturing plant will begin operations on March 21 at the Austin, Texas Gigafactory.
Musk initially referenced the initiative during a January 2026 investor call before specifying the Austin site in a March 14 post on X. The manufacturing facility will occupy space within Tesla’s expansive 2,500-acre Gigafactory Texas property.
The fundamental rationale is straightforward: Musk anticipates Tesla will face chip supply limitations. “When I look ahead and say what’s the limiting factor for Tesla growth, if you go 3 or 4 years out, I think it actually is chip production,” he explained to investors in January.
He additionally identified memory and AI logic capacity as possible constraints. “Is there enough AI logic and enough memory, enough RAM for our volume?” Musk questioned during the call.
Why Tesla Is Building Its Own Chips
Morgan Stanley analyst Andrew Percoco outlined the projections. Should Tesla achieve its long-range Optimus humanoid robot production objective of 100 million-plus units annually, the company would require over 200 million chips each year. This represents more than a 50-fold increase compared to Tesla’s present chip requirements across its automotive and robotaxi divisions.
Percoco indicated Tesla’s choice to develop in-house chip manufacturing capability stems from two factors: geopolitical considerations and the Optimus initiative. Company leadership identified AI compute as a potential bottleneck emerging within three to four years.
Musk spoke plainly regarding the geopolitical dimension. He stated the Terafab must encompass “logic, memory and packaging domestically” to safeguard against supply chain vulnerabilities. “I think people may be underweighting some of the geopolitical risks,” he remarked.
Constructing a fabrication plant demands substantial capital and time. As a reference point, Micron’s Boise memory chip facility commenced construction in 2022 with chip production anticipated to begin in 2027.
Cost and Scale of the Project
Percoco projects Tesla may encounter costs between $35 billion and $40 billion for its proprietary chip fabrication capacity. Even under favorable conditions, he anticipates chips wouldn’t enter production until 2028.
This investment level represents a significant departure from Tesla’s standard capital expenditure patterns. The company typically allocates under $10 billion annually for manufacturing facilities and equipment, though it has announced plans to invest $20 billion in 2026 as it expands its robotics operations.
Percoco characterized the fabrication plant as a “Herculean task” and suggested Tesla might alternatively pursue partnerships with established chipmakers instead of pursuing independent development. He maintains a Hold rating on Tesla stock with a $415 price target.
Tesla shares entered Wednesday’s trading session with an 11% decline year-to-date while showing a 77% gain over the trailing 12 months. The S&P 500 and Dow Jones futures both registered modest gains during the day.
The Terafab facility is scheduled to officially commence operations on March 21.
